Starpharma Holdings Ltd
OTC:SPHRY
Starpharma Holdings Ltd
OTC:SPHRY
Price:
5
USD
-4.76%
Market Closed
Market Cap:
$206m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
S
|
Starpharma Holdings Ltd
OTC:SPHRY
|
AU |
|
G
|
G-III Apparel Group Ltd
F:GI4
|
US |
|
R
|
Reading International Inc
F:46B
|
US |
|
E.ON SE
F:EOAA
|
DE |
|
B
|
Bread Financial Holdings Inc
XMUN:LID
|
US |
|
W
|
Wendel SE
DUS:WIS
|
FR |
|
H
|
HeidelbergCement AG
F:HEI
|
DE |
|
Capital Ltd
F:C8D
|
UK |
|
SoFi Technologies Inc
NASDAQ:SOFI
|
US |
Wall St Price Targets
SPHRY Price Targets Summary
Starpharma Holdings Ltd
Starpharma Holdings Ltd
Wall Street analysts forecast SPHRY stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for SPHRY is 6.58 USD with a low forecast of 6.52 USD and a high forecast of 6.77 USD.
Lowest Forecast
Price Target
6.52
USD
30% Upside
Average Forecast
Price Target
6.58
USD
32% Upside
Highest Forecast
Price Target
6.77
USD
35% Upside
Starpharma Holdings Ltd Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is SPHRY's stock price target?
Price Target
6.58
USD
6.58
USD
According to Wall Street analysts, the average 1-year price target for SPHRY is 6.58 USD with a low forecast of 6.52 USD and a high forecast of 6.77 USD.
What is the Revenue forecast for Starpharma Holdings Ltd?
Projected CAGR
82%
82%
Over the last 13 years, the compound annual growth rate for Revenue has been 4%. The projected CAGR for the next 4 years is 82%.
